These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34085257)

  • 1. Targeted RNA m
    Liu XM; Qian SB
    Methods Mol Biol; 2021; 2298():399-414. PubMed ID: 34085257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmable RNA N
    Liu XM; Zhou J; Mao Y; Ji Q; Qian SB
    Nat Chem Biol; 2019 Sep; 15(9):865-871. PubMed ID: 31383972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cellular mRNAs translation by CRISPR-Cas9.
    Liu Y; Chen Z; He A; Zhan Y; Li J; Liu L; Wu H; Zhuang C; Lin J; Zhang Q; Huang W
    Sci Rep; 2016 Jul; 6():29652. PubMed ID: 27405721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cas9 immunity creates challenges for CRISPR gene editing therapies.
    Crudele JM; Chamberlain JS
    Nat Commun; 2018 Aug; 9(1):3497. PubMed ID: 30158648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directed Evolution of CRISPR-Cas9 Base Editors.
    Winter J; Perez-Pinera P
    Trends Biotechnol; 2019 Nov; 37(11):1151-1153. PubMed ID: 31623959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted manipulation of m
    Sun X; Wang DO; Wang J
    Methods; 2022 Jul; 203():56-61. PubMed ID: 35306148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in therapeutic application of CRISPR-Cas9.
    Sun J; Wang J; Zheng D; Hu X
    Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.
    Pei WD; Zhang Y; Yin TL; Yu Y
    Brief Funct Genomics; 2020 May; 19(3):215-228. PubMed ID: 31819946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmable RNA N
    Shi C; Zou W; Liu X; Zhang H; Li X; Fu G; Fei Q; Qian Q; Shang L
    Plant Biotechnol J; 2024 Jul; 22(7):1867-1880. PubMed ID: 38363049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoactivatable RNA N
    Zhao J; Li B; Ma J; Jin W; Ma X
    Small; 2020 Jul; 16(30):e1907301. PubMed ID: 32583968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.
    Chaterji S; Ahn EH; Kim DH
    Theranostics; 2017; 7(18):4445-4469. PubMed ID: 29158838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.